THRL vs. AGR, IHR, LABS, MXF, PHP, IWG, BYG, DLN, GPOR, and LXI
Should you be buying Target Healthcare REIT stock or one of its competitors? The main competitors of Target Healthcare REIT include Assura (AGR), Impact Healthcare REIT (IHR), Life Science REIT (LABS), Medicx Fund (MXF), Primary Health Properties (PHP), IWG (IWG), Big Yellow Group (BYG), Derwent London (DLN), Great Portland Estates (GPOR), and Lxi Reit (LXI). These companies are all part of the "real estate" sector.
Target Healthcare REIT vs. Its Competitors
Assura (LON:AGR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.
67.2% of Assura shares are owned by institutional investors. Comparatively, 54.4% of Target Healthcare REIT shares are owned by institutional investors. 0.9% of Assura shares are owned by company insiders. Comparatively, 0.0% of Target Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Assura had 1 more articles in the media than Target Healthcare REIT. MarketBeat recorded 3 mentions for Assura and 2 mentions for Target Healthcare REIT. Target Healthcare REIT's average media sentiment score of 0.51 beat Assura's score of 0.35 indicating that Target Healthcare REIT is being referred to more favorably in the news media.
Assura currently has a consensus target price of GBX 60, indicating a potential upside of 26.37%. Given Assura's stronger consensus rating and higher probable upside, analysts clearly believe Assura is more favorable than Target Healthcare REIT.
Target Healthcare REIT has a net margin of 104.99% compared to Assura's net margin of -18.09%. Target Healthcare REIT's return on equity of 10.78% beat Assura's return on equity.
Assura has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.
Target Healthcare REIT has lower revenue, but higher earnings than Assura. Target Healthcare REIT is trading at a lower price-to-earnings ratio than Assura, indicating that it is currently the more affordable of the two stocks.
Assura pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.1%. Target Healthcare REIT pays an annual dividend of GBX 0.06 per share and has a dividend yield of 0.1%. Assura pays out 63.4% of its earnings in the form of a dividend. Target Healthcare REIT pays out 0.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Summary
Assura beats Target Healthcare REIT on 10 of the 18 factors compared between the two stocks.
Get Target Healthcare REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Target Healthcare REIT Competitors List
Related Companies and Tools
This page (LON:THRL) was last updated on 10/23/2025 by MarketBeat.com Staff
